Skip to main content

Table 2 Comorbidities

From: The impact of multimorbidity on foot health outcomes in podiatry patients with musculoskeletal foot pain: a prospective observational study

Condition, n (%)

Diagnosed with condition

Receiving treatment for condition

Condition limits activities

Heart disease

12 (10.4)

10 (8.7)

6 (5.2)

High blood pressure

23 (20)

18 (15.7)

6 (5.2)

Lung disease

11 (9.6)

8 (7.0)

4 (3.5)

Diabetes

7 (6.1)

4 (3.5)

3 (2.6)

Ulcer/stomach disease

13 (11.3)

11 (9.6)

6 (5.2)

Kidney disease

3 (2.6)

1 (0.9)

2 (1.7)

Liver disease

3 (2.6)

1 (0.9)

1 (0.9)

Anaemia or other blood disease

10 (8.7)

6 (5.2)

6 (5.2)

Cancer

6 (5.2)

2 (1.7)

2 (1.7)

Depression

20 (17.4)

11 (9.6)

15 (13.0)

Osteoarthritis or degenerative arthritis

38 (33.0)

24 (20.9)

32 (27.8)

Back Pain

50 (43.5)

22 (19.1)

34 (29.6)

Rheumatoid or inflammatory arthritis

9 (7.8)

5 (4.3)

6 (5.2)

Other medical problems

44 (38.3)

–

–

 Rheumatic or musculoskeletal diseasesa

7 (6.1)

–

–

 Neurological conditionsb

9 (7.9)

–

–

 Hypo/hyper thyroidism

5 (4.4)

–

–

 Asthma

4 (3.5)

–

–

 Sleep apnoea

3 (2.6)

–

–

 Other

16 (13.9)

–

–

  1. agout, mixed connective tissue disease, Sjogren’s syndrome, ankylosing spondylitis, fibromyalgia, osteopenia, and benign hypermobility (all n = 1)
  2. bstroke/transient ischaemic attack (n = 3), trigeminal neuralgia, multiple sclerosis, Parkinson’s disease, epilepsy, polio, and neuropathy (all n = 1)
  3. N Number of participants